Most studies evaluating basal insulin added to OAMs in T2D note a decrease in A1C from baseline up to ∼12 weeks, after which they stabilize [4,5]; whereas, in the present study, the improvement in A1C continued in the G+L group until 24 weeks. Here, INS is linked to type 2 diabetes mellitus.